Quantbot Technologies LP Cogent Biosciences, Inc. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$10.65 - $14.84 $210,870 - $293,832	-19,800 Reduced 90.41%	2,100 $24,000
Q3 2022 Nov 07, 2022	BUY	$9.39 - $16.99 $149,301 - $270,141	15,900 Added 265.0%	21,900 $326,000
Q2 2022 Aug 09, 2022	BUY	$3.92 - $9.73 $14,112 - $35,028	3,600 Added 150.0%	6,000 $54,000
Q1 2022 May 16, 2022	SELL	$5.31 - $8.7 $2,124 - $3,479	-400 Reduced 14.29%	2,400 $17,000
Q4 2021 Feb 11, 2022	BUY	$7.51 - $10.81 $21,028 - $30,268	2,800 New	2,800 $24,000

170

113M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $585M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.